A Pragmatic Trial Integrating Homelessness Diversion Services Into an Emergency Department Discharge System

Sponsor
The University of Texas Health Science Center, Houston (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05823220
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD) (NIH)
1,000
1
2
28
35.7

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether a homelessness diversion program integrated into a hospital emergency department (ED) will lower ED use, to identify characteristics of individuals most likely to benefit from homelessness diversion and to discover opportunities to tailor Homelessness Diversion (HD) services to better meet the needs of diverse communities.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Homeless diversion (HD)
  • Behavioral: Treatment-as-usual (TAU)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1000 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
A Pragmatic Randomized Trial Integrating Homelessness Diversion Services Into an Emergency Department Discharge System
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Mar 1, 2025
Anticipated Study Completion Date :
Aug 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Homeless diversion (HD) group

Behavioral: Homeless diversion (HD)
Participants will receive services from specialty-trained community health workers and will be invited to complete monthly assessments via text and phone to assess their health and housing for 6 months and to share feedback on their experience with the intervention after completion by a text message to a link for the survey

Active Comparator: Treatment-as-usual (TAU) group

Behavioral: Treatment-as-usual (TAU)
Participants will receive a list of community resources they can contact to receive services and will be invited to complete monthly assessments via text and phone to assess their health and housing for 6 months and to share feedback on their experience with the intervention after completion by a text message to a link for the survey

Outcome Measures

Primary Outcome Measures

  1. Number of ED visits [end of study (6 months after start of study)]

Secondary Outcome Measures

  1. Number of participants who experience homelessness [end of study (6 months after start of study)]

  2. Change in health related quality of life as assessed by the Short Form-12 version 2.0 (SF12v2) health Survey [baseline, month 1, month 2, month 3, month 4, month 5 and month 6]

    This is a 12 item questionnaire and scores range from 0 to 100, where a zero score indicates the lowest level of health and 100 indicates the highest level of health.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • English or Spanish speaking

  • discharged from a Harris Health Hospital ED (Ben Taub or LBJ)

  • at imminent risk of homelessness

  • patients with Medicaid, Medicare or who are uninsured

Exclusion Criteria:
  • having a conservator (legal guardian)

  • plans to move away from Texas in 6 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 The University of Texas Health Science Center at Houston Houston Texas United States 77030

Sponsors and Collaborators

  • The University of Texas Health Science Center, Houston
  • National Institute on Minority Health and Health Disparities (NIMHD)

Investigators

  • Principal Investigator: Jack Tsai, PhD, The University of Texas Health Science Center, Houston

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jack Tsai, Professor, The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier:
NCT05823220
Other Study ID Numbers:
  • HSC-SPH-22-0762
  • R01MD018213
First Posted:
Apr 21, 2023
Last Update Posted:
Apr 21, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 21, 2023